Step Therapy Supposedly Minimizes Risk, but for Brittany it Caused Severe Complications

  The Providence Journal recently published an article by Brittany Ricci, a student at Brown University’s Alpert Medical School, detailing her year-long struggle to receive the treatment her doctor had prescribed…

Continue Reading Step Therapy Supposedly Minimizes Risk, but for Brittany it Caused Severe Complications
The Drug Stelara Gains Approval for Moderate to Severe Ulcerative Colitis in the EU
pixel2013 / Pixabay

The Drug Stelara Gains Approval for Moderate to Severe Ulcerative Colitis in the EU

According to a story from BioSpace, Janssen Pharmaceutical Companies recently announced that the European Commission (EC) has expanded the approved indication of the company's drug ustekinumab (marketed as Stelara). This…

Continue Reading The Drug Stelara Gains Approval for Moderate to Severe Ulcerative Colitis in the EU
Abivax Begins Enrollment in Phase 2b Study of Experimental Ulcerative Colitis Treatment
jarmoluk / Pixabay

Abivax Begins Enrollment in Phase 2b Study of Experimental Ulcerative Colitis Treatment

According to a press release from French biotechnology company Abivax, the Company has successfully begun recruitment for its phase 2b clinical study of ABX464, its experimental once-a-day ulcerative colitis medication.…

Continue Reading Abivax Begins Enrollment in Phase 2b Study of Experimental Ulcerative Colitis Treatment

As the Rate of Ulcerative Colitis Diagnoses Grows, its Clear More Research is Needed

Inflammatory Bowel Disease Inflammatory bowel disease (IBD) is actually a term used to classify a few different conditions. Two of these are Crohn's disease and ulcerative colitis.  These are rare…

Continue Reading As the Rate of Ulcerative Colitis Diagnoses Grows, its Clear More Research is Needed
Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
stevepb / Pixabay

Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA

According to a story from Ankylosing Spondylitis News, the drug Hadlima, which is a biosimilar to the drug Humira (adalimumab), was recently approved by the US Food and Drug Administration…

Continue Reading Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA

Canadian Study Indicates That Prescribing Practices of Infliximab for Ulcerative Colitis Need Amendment

Inflammatory Bowel Diseases Inflammatory bowel diseases (IBD) is the overarching term for both ulcerative colitis and Crohn's disease. In Canada, there are around 270,000 individuals living with the one of…

Continue Reading Canadian Study Indicates That Prescribing Practices of Infliximab for Ulcerative Colitis Need Amendment

Acute Lymphoblastic Leukemia: Miracles for Millions and the People Who Created Them

  According to a recent article in MedicalXpress, the story begins fifty years ago with the grim statistics that a child with acute lymphoblastic leukemia (ALL) would not survive longer than…

Continue Reading Acute Lymphoblastic Leukemia: Miracles for Millions and the People Who Created Them

A New Potential Drug Target for Inflammatory Diseases such as Ulcerative Colitis Discovered

Claudia Stäubert and her team of researchers at the University of Leipzig have just reported noteworthy findings which could impact the future treatment of inflammatory diseases. Lactic acid bacteria, or…

Continue Reading A New Potential Drug Target for Inflammatory Diseases such as Ulcerative Colitis Discovered
Innovative New Test Could Allow for Inflammatory Bowel Disease Patients to Receive More Personalized Treatment
WolfBlur / Pixabay

Innovative New Test Could Allow for Inflammatory Bowel Disease Patients to Receive More Personalized Treatment

According to a story from EurekAlert!, a team of scientists affiliated with the University of Cambridge have pioneered a new test that could herald a new development in the treatment…

Continue Reading Innovative New Test Could Allow for Inflammatory Bowel Disease Patients to Receive More Personalized Treatment
Inflammatory Bowel Disease Patient Wellness Chatbot Starts 6-Week Test Run
https://pixabay.com/en/technology-robot-human-hand-2025795/

Inflammatory Bowel Disease Patient Wellness Chatbot Starts 6-Week Test Run

According to an article from CW associate WBCB, Dutch startup Nori Health has started open enrollment in the six-week test of its eponymous experimental chatbot, Nori. Nori aims to help…

Continue Reading Inflammatory Bowel Disease Patient Wellness Chatbot Starts 6-Week Test Run

Edible Antibodies Halt E. Coli in Pigs, Could Help End Overuse of Antibiotics

According to a publication at BioPortfolio, Belgian researchers are developing an orally-administered antibody medication for patients living with gastrointestinal disorders. In most cases, antibodies are injected into the bloodstream for…

Continue Reading Edible Antibodies Halt E. Coli in Pigs, Could Help End Overuse of Antibiotics
Despite New Inflammatory Bowel Disease Therapies, Difficulty Treating Persists
source: pixabay.com

Despite New Inflammatory Bowel Disease Therapies, Difficulty Treating Persists

In a recent video interview with Healio, Dr. David Rubin recapped some of his discussion at the 2019 Interdisciplinary Autoimmune Summit. At the summit, he and his colleagues spoke about…

Continue Reading Despite New Inflammatory Bowel Disease Therapies, Difficulty Treating Persists

Simple Blood Test Could Prevent Serious Side Effects for Inflammatory Bowel Disease Treatment

Inflammatory Bowel Disease Inflammatory bowel disease (IBD) is the collective term used to describe ulcerative colitis and Crohn's disease. These conditions cause diarrhea, rectal bleeding, fatigue, weight loss, and rectal bleeding. These…

Continue Reading Simple Blood Test Could Prevent Serious Side Effects for Inflammatory Bowel Disease Treatment